News on September 11: A comprehensive solution provider for innovative devices in chronic pain ——New Cloud Medical Technology Co., Ltd.(hereinafter referred to as "New Cloud Medical"") Announced CompletionB+ Round Financing. This round of financing was led byDaoTong InvestmentLeading investment,Taizhou Angel Fund、Qianfeng InvestmentFollow-up investment.

New Cloud Medical, established in 2016, focuses on utilizing medical technology to address the challenges in chronic pain treatment. Through an integrated "industry-university-research-application" model, the company continuously drives innovation in its product pipeline, ranging from non-invasive transcutaneous electrical stimulation devices to minimally invasive interventional instruments and active implantable devices. Multiple products have broken the technological monopolies held by foreign companies in related fields, achieving revolutionary breakthroughs in cutting-edge technologies such as AI-closed loop spinal cord stimulation. These innovations will provide precise, safe, and effective treatment options for patients with chronic pain. This round of financing has brought new capital support to New Cloud Medical and once again demonstrated the capital market's confidence in the company’s commercialization capabilities.

"From the perspective of human development, pain is an eternal topic, especially as people's quality of life improves, pain issues have become very prominent. Chinese enterprises utilizing cutting-edge technology to address pain problems can help reduce social burdens and decrease household expenses."Founder & CEO of New Cloud Medical, Zhao YunOn the Significance of Targeting the Pain Management Sector

"Our R&D innovation lies in the application of the industry-academia-research-medical model, which is also our core competitiveness."Zhao Yun introduced,The so-called "Integration of Industry, Academia, Research, Medical Application, and Clinical Use" involves in-depth cooperation with well-known hospitals, universities, and research institutions both in China and abroad. It creates a "five-in-one" model driven by scientific research, engineering R&D transformation, industrial application, clinical validation and feedback, and user scenario orientation to ensure continuous innovation capabilities and maintain a competitive edge in the market.

Currently, New Cloud Medical has jointly undertaken the Beijing Science and Technology Plan project "Research and Development of AI Closed-loop Implantable Spinal Cord Stimulator" with the Institute of Electrical Engineering of the Chinese Academy of Sciences and the China Rehabilitation Research Center. It has also collaborated with Beijing University of Chemical Technology to develop several new medical materials.

Partner of Daotong Investment, Lin ZhenchengAs the aging society accelerates, the demand for chronic pain diagnosis and treatment shows a rigid increase. New Cloud Medical has long been deeply engaged in the field of pain management. With differentiated technical layouts and efficient product development capabilities, it has developed multiple innovative pain management devices, such as closed-loop spinal nerve stimulators and minimally invasive kits for ligamentum flavum resection, significantly improving the accessibility of advanced pain treatment technologies. We firmly believe that New Cloud Medical will continue to bring breakthrough solutions to the industry, and we will support the company in promoting its innovative products in the global market over the long term.

Zhang Xiaoyan, Partner of Taizhou Angel Investment FundWe are optimistic about the long-term prospects of product development in the non-drug treatment field for chronic pain. New Cloud Medical, with its solid research foundation and clear product roadmap, has taken significant strides in China, particularly in closed-loop spinal cord stimulation technology. This provides an effective and safe new solution for chronic pain treatment and demonstrates strong capabilities to ensure continuous innovation in core technologies. We look forward to the clinical progress and expanded indications of New Cloud Medical's product series, which will benefit more patients.